-+ 0.00%
-+ 0.00%
-+ 0.00%

MEDICENNA REPORTS POTENT CD122 BLOCKADE AND EXTENDED SURVIVAL WITH MDNA209 IN PRECLINICAL MODELS OF AUTOIMMUNE DISEASE

Reuters·10/26/2026 12:52:38

Please log in to view news